Bank of Montreal’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16K | Hold |
780
| – | – | ﹤0.01% | 3009 |
|
|
2025
Q1 | $16K | Hold |
780
| – | – | ﹤0.01% | 2961 |
|
|
2024
Q4 | $17.7K | Sell |
780
-75
| -9% | -$1.7K | ﹤0.01% | 2950 |
|
|
2024
Q3 | $21K | Sell |
855
-215
| -20% | -$5.28K | ﹤0.01% | 3219 |
|
|
2024
Q2 | $25.8K | Hold |
1,070
| – | – | ﹤0.01% | 3251 |
|
|
2024
Q1 | $26.8K | Sell |
1,070
-785
| -42% | -$19.7K | ﹤0.01% | 3255 |
|
|
2023
Q4 | $43.2K | Sell |
1,855
-94
| -5% | -$2.19K | ﹤0.01% | 3171 |
|
|
2023
Q3 | $44.1K | Sell |
1,949
-650
| -25% | -$14.7K | ﹤0.01% | 3013 |
|
|
2023
Q2 | $63.9K | Sell |
2,599
-710
| -21% | -$17.5K | ﹤0.01% | 3160 |
|
|
2023
Q1 | $77.1K | Sell |
3,309
-1,080
| -25% | -$25.2K | ﹤0.01% | 3012 |
|
|
2022
Q4 | $111K | Sell |
4,389
-2,354
| -35% | -$59.4K | ﹤0.01% | 2912 |
|
|
2022
Q3 | $200 | Buy |
6,743
+4,013
| +147% | +$119 | ﹤0.01% | 2778 |
|
|
2022
Q2 | $83 | Hold |
2,730
| – | – | ﹤0.01% | 3065 |
|
|
2022
Q1 | $97K | Sell |
2,730
-56
| -2% | -$1.99K | ﹤0.01% | 3167 |
|
|
2021
Q4 | $126K | Buy |
2,786
+88
| +3% | +$3.98K | ﹤0.01% | 3002 |
|
|
2021
Q3 | $147K | Buy |
2,698
+628
| +30% | +$34.2K | ﹤0.01% | 3186 |
|
|
2021
Q2 | $107K | Buy |
+2,070
| New | +$107K | ﹤0.01% | 3181 |
|
|
2020
Q4 | – | Sell |
-60
| Closed | -$2K | – | 4471 |
|
|
2020
Q3 | $2K | Buy |
+60
| New | +$2K | ﹤0.01% | 4207 |
|